BF/PC-21

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameBF/PC-21
Drug Alias Namecathepsin X inhibitors (Biofrontera)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin K inhibitors
TargetsCathepsin K
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiofrontera Bioscience Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiofrontera Bioscience Gmbh
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A